ToolGen Incorporated Logo

ToolGen Incorporated

A biotech firm licensing genome editing patents for therapeutics and agriculture.

199800 | KO

Overview

Corporate Details

ISIN(s):
KR7199800004
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡중앙로 172 바이오이노베이션파크,8층, 강서구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ToolGen Incorporated is a biotechnology company specializing in the development and application of genome editing technology. A pioneer in the field since 1999, the company has developed three successive generations of gene editing tools: Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), and the CRISPR-Cas9 system. ToolGen holds foundational patents for CRISPR-Cas9 technology, claiming to be the first to file a patent for its use in eukaryotic cells. The company's business model is centered on three core areas: monetizing its intellectual property through licensing and collaboration, developing proprietary therapeutic programs in gene and cell therapy, and applying its technology to improve agricultural crops.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 00:00
Share Issue/Capital Change
전환청구권행사
Korean 10.8 KB
2025-09-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 92.5 KB
2025-09-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-09-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 118.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.8 MB
2025-08-04 00:00
Share Issue/Capital Change
전환가액의조정
Korean 11.2 KB
2025-07-08 00:00
Regulatory News Service
자산재평가결과(자율공시)
Korean 10.8 KB
2025-06-27 00:00
Regulatory News Service
자산재평가실시결정(자율공시)
Korean 5.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.9 MB
2025-04-01 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 102.6 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 25.7 KB
2025-03-28 00:00
Board/Management Information
대표이사변경
Korean 9.1 KB
2025-03-20 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 460.2 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 26.2 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 181.9 KB

Automate Your Workflow. Get a real-time feed of all ToolGen Incorporated filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ToolGen Incorporated

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ToolGen Incorporated via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

PRAP Japan,Inc. Logo
A PR & communications firm building brand reputation for corporate clients in diverse industries.
Japan
2449
Predictive Oncology Inc. Logo
AI platform uses a vast tumor biobank to predict drug response and accelerate oncology discovery.
United States of America
POAI
Prime Medicine, Inc. Logo
Developing 'search and replace' gene editing therapies to treat genetic disorders.
United States of America
PRME
ProPhase Labs, Inc. Logo
Genomics, diagnostics, contract manufacturing, and OTC health & wellness solutions provider.
United States of America
PRPH
PROTHENA CORP PUBLIC LTD CO Logo
Advancing antibody-based therapies for neurodegenerative and rare amyloid diseases.
United States of America
PRTA
Psomagen, Inc. Logo
A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.
United States of America
950200
Public Policy Holding Company, Inc. Logo
Advisory group providing public policy, government relations, and strategic communications services.
United States of America
PPHC.L
Purple Biotech Ltd. Logo
Developing cancer therapies to overcome tumor immune evasion and drug resistance.
Israel
PPBT
Qualigen Therapeutics, Inc. Logo
A clinical-stage company developing innovative treatments for rare cancers in adults and children.
United States of America
QLGN
QUIA PHARMA AB Logo
Develops biobetters by enhancing approved drugs with a patented drug delivery platform.
Sweden
QUIA

Talk to a Data Expert

Have a question? We'll get back to you promptly.